Both Sides of the Table

SEPTEMBER 8, 2009

I was reading Chris Dixon’s blog tonight. I came across this blog post about getting a computer science degree as the best degree for getting into venture capital or working at a VC-backed start up. And if it’s not I’m generally not that interested in funding it. I had to laugh a bit reading it.

Startup

Both Sides of the Table

FEBRUARY 8, 2015

I live in LA and fund startups. So my advice to many is to study online companies that understand how to use technology for audience development, engagement, viral distribution and subscriptions. Usually I tell them to study Upworthy & Buzzfeed. So you can imagine that I see a lot of video startups. Most will fail.

Company

Both Sides of the Table

JULY 14, 2010

So they create a task list of all the marketing activities an organization can do: press releases, web site updates, customer case studies, blog posts, daily Tweets, Facebook fan page, attending conferences, etc. They’re tasked with doing … marketing. You get a lot of traffic – not always results.

Startup

Both Sides of the Table

SEPTEMBER 21, 2016

The news blogs will cover the what, how and how much but I want to focus on the “why” and try to be instructive of what I think makes for a great A-round startup. I speak a lot on college campuses and entrepreneur events and amongst the most common things I’m asked to talk about are: What do VCs fund?

Design

Xconomy

MAY 19, 2020

Amplyx Pharmaceuticals has completed enrollment in one mid-stage trial of its lead drug candidate, a new kind of antifungal treatment, and has finished treating the first patients in two more such studies.

San Diego

Both Sides of the Table

MAY 7, 2011

Sometime around 2003/04 my technology team turned me on to “Spolsky on Software&# a periodic newsletter served up blog style from Joel Spolsky of FogCreek Software, a maker of bug-tracking software. Blogs weren’t popularized yet so it was an oddity for me to read the founder of a software company spewing out advice.

Software Review

Both Sides of the Table

MARCH 21, 2013

I recently wrote a blog post in which I pointed out that many investors & advisors discourage enterprise startups from having a professional services (PS) business and I think this is a big mistake. Hopefully it’s not as a way of avoiding fund raising or finding quick pockets of money. ” Photo credit Food52.

Software Review

Both Sides of the Table

OCTOBER 31, 2015

And actually if you have ADD you may just want to watch the videos I’ve embedded below because it’s easier to concentrate on that than reading a blog post. I can’t write a blog post and then wait 3 days to publish. I study for tests last minute. Of course you should go on your own journey of discovery.

Startup

Both Sides of the Table

NOVEMBER 4, 2010

About how dismissive traditional print was about blogs or the airlines views the “peanut serving&# Southwest Airlines. Perhaps the best they can do is to help fund their successors. I am reminded about how dismissive traditionally television media is about YouTube – even to this day. About how Microsoft viewed Google Apps.

Startup

Both Sides of the Table

APRIL 13, 2011

Brad on blogging. How did you start blogging? “My My initial desire to blog came from something that’s always been my approach to investing – I’m a nerd and I love to play with the technology and part of my approach has really been to understand things both at a user level and at a reasonably deep tentacle level.

Venture Capital

InfoChachkie

DECEMBER 8, 2011

Of the 80 companies that have completed the program since its 2007 inception, 49 have received funding, 8 have been acquired and 8 have ceased operations. I began our discussion by asking Brad what motivated him to co-author Venture Deals , rather than continuing to share venture capitalists’ secrets via his Ask The VC blog.

Venture Capital

SoCal CTO

NOVEMBER 17, 2009

Sometimes I make a blog entry. Some days I respond to questions asked by folks like yourself, the press, or an entity doing a case study, i.e. Citrix, RIM, USC. You've been blogging for a while, what are five good posts that I should check out? My company and I are a perfect case study for the Tech Council affiliation.

Acquisition

Both Sides of the Table

NOVEMBER 14, 2010

That would mean that the increased number of new business startups will lead to a “funding gap&# of deals that can’t get financed. Most of my MBA classes were a waste (since I had studied economics as an undergrad) but one totally changed my thinking. That is conformity. People buy at the wrong times.

Invest

Xconomy

OCTOBER 1, 2018

The new VelosBio cash is earmarked for completing the work needed to proceed into human studies. These drugs are meant to provide a targeted strike to tumors, sparing healthy tissue. The specific cancers that VelosBio. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego

Both Sides of the Table

JULY 23, 2013

Every time I approached Network Solutions (or any technical group in Accenture) they wrote me off as “a business guy” since I studied economics and was on the Accenture “business track.” They said, “we’ve seen you in action across 2 companies and could really use somebody with your skills at our fund.”

Technical Advisors

Xconomy

NOVEMBER 9, 2018

A 10-person team of researchers at the Salk Institute for Biological Studies has been awarded an eight-year, $19.2 Allen Frontiers Group to fund brain health research. million grant to investigate mechanisms underlying Alzheimer’s disease and aging-related cognitive decline and uncover new therapies.

Research

Startup Professionals Musings

SEPTEMBER 27, 2011

I still plan to publish on this blog occasionally, as well as more frequently on my blogs at Forbes , Huffington Post , and others. Studies show that anyone can be an entrepreneur, but many won’t be happy as entrepreneurs. Finding funding for startups is a tough process. I learn something new every day in blogging.

Entrepreneur

Both Sides of the Table

SEPTEMBER 6, 2010

I’ve said versions of it on this blog before so I hope it’s not too repetitive. But here’s my rationale: I see way too many employees trying to understand all of the complexities and spending way too much time trying to calculate how much their options are worth through each fund raising round. I think you will.

Startup

Both Sides of the Table

APRIL 17, 2016

Rozovsky basically said that having studied 180 teams at Google over the past several years and trying to determine what made some teams perform better than others (despite every team being filled with over-achievers who work at Google) one factor stood out more than others: Creating “psychologically safe environments.”

Coach

Xconomy

DECEMBER 18, 2019

More than 250 miles above the Earth’s surface aboard the International Space Station, a first-in-kind study of neurodegenerative disease is expected to reveal never-before-seen cell interactions.

Research

socalTECH

NOVEMBER 17, 2010

Last week, Los Angeles-based MOVIECLIPS.COM (www.movieclips.com) announced the firm's Series A funding round, worth $3M, from Shasta Ventures, First Round Capital, and a number of Silicon Valley angels. Studies show, if you don't, people will turn to piracy. Now that you have the funding in hand, what are you working on?

Startup

Xconomy

MARCH 2, 2020

With one investigational cancer drug in Phase 1 testing and a second one approaching the clinic, ORIC Pharmaceuticals is looking to tap the public markets for funds to finance that research. The company’s lead drug, ORIC-101, is under evaluation in Phase 1b studies in combination with enzalutamide (Xtandi) in prostate cancer and.

Study

Xconomy

JANUARY 11, 2017

A recent study by EdSurge , an edtech information firm, shows venture funding for U.S. Those stats track with the overall trend in VC funding nationally: the industry saw a “correction” or “normalization” downward after hitting a peak in 2015. education tech companies totaled $1.03

Funding

Xconomy

FEBRUARY 22, 2017

The company, headquartered in Cranbury, NJ, disclosed this morning that it has raised a $74 million Series B round from Topspin Biotech Fund, Euclidian Capital, InterWest Partners, OrbiMed Advisors, and Osage University Partners. PMV raised a $30 million Series A in 2014. Read more » Reprints | Share:

Study

Xconomy

JANUARY 9, 2019

The cash tops off a Series B round of funding announced last year. The Boston company, which counts diabetes drug giants Eli Lilly (NYSE: LLY ) and Novo Nordisk (NYSE: NVO ) among its investors and partners, says the capital will support Phase 3 studies of its device this year, and if all goes well, an application for FDA approval.

Study

Tech Zulu Event

SEPTEMBER 21, 2012

Students and teachers could rarely be friends on Facebook and no student would want their Physics or Math teacher telling them to study thoroughly for their term paper, but things change and so do we. They add yet another study. Ann Arbor SPARK Accelerated. Students Professional Network. Online Evaluation For Placement.

Help

Xconomy

FEBRUARY 14, 2020

Post-marketing studies aim to identify side effects not observed in the first three phases of testing. This week, results of such a study led to the market withdrawal of weight-loss pill lorcaserin (Belviq). But the post-marketing study revealed a higher incidence of.

Study

Xconomy

AUGUST 11, 2016

government has ambitious plans for a long-term health study with one million Americans, and one of the world’s most powerful tech companies has a big part to play, including the storage of all the data on its “cloud” servers. The first year of the grant for the Data and Research Support Center is worth $13.6

PMI

Xconomy

AUGUST 17, 2016

San Diego’s Avelas Biosciences , founded in 2009 to advance a fluorescing biologic agent intended to help surgeons differentiate cancerous tissue from healthy tissue, has completed a $20 million Series C round of venture funding. The Phase 1b study also determined a preferred dose for the next stage in the study.

Avalon

Xconomy

APRIL 11, 2017

A $40 million transfusion led by Frazier Healthcare Partners and Denmark’s Novo A/S is bringing fresh life to a Michigan biotech working to advance a new experimental drug for treating a type of non-alcoholic fatty liver disease.

Study

Xconomy

JUNE 21, 2018

Eidos will use the cash to fund studies of AG10 , a drug in mid-stage testing for transthyretin (TTR) amyloidosis, a progressive and fatal condition caused by the. The San Francisco company priced its IPO late Tuesday, selling 6.25 million shares at $17 each, which was on the high end of its projected $15 to $17 range.

Study

Xconomy

OCTOBER 5, 2016

The idea for the funding program, called Safe Genes, is to get out ahead of problems that could bring the field to a screeching halt. He praised DARPA for looking to fund “safety first, rather than jumping to fund unsafe work with only a handful of potential applications.” Some see it as a way to eradicate malaria.)

Research

Xconomy

SEPTEMBER 15, 2016

San Diego’s innovation clusters continued to grow in 2015, as local startups, funding deals, and job growth extended an economic growth spurt that began in 2013. That’s according to a report being released today by Connect, the local nonprofit group focused on technology and entrepreneurship.

San Diego

Xconomy

DECEMBER 21, 2018

Before you fly off, or drive, or simply unplug, check out our preview of what could be next year’s top clinical studies; the tumult in big pharma’s on again-off again relationship with consumer healthcare; big names on the move in the nation’s capital; and a flurry of year-end deals.

Pricing

Xconomy

APRIL 18, 2018

The biotech, 10xBio, announced earlier this month that the FDA had approved its application to begin clinical trials in Phase 1b/2a studies testing the unnamed injectable drug. The studies are intended to establish the safety and tissue responses of the injectable drug, said Dobak, who is the chairman.

San Diego

Xconomy

NOVEMBER 3, 2017

Studies in mice have. Plante is a technology industry veteran in San Diego who has served as the CEO of Bel-Tronics, and as the founding CEO of SmartDrive Systems and Pathway Genomics. The klotho gene was identified in 1997, and encodes a protein that is produced primarily in the kidney.

San Diego

Xconomy

SEPTEMBER 27, 2016

[ Note: The headline has been corrected to better describe the company’s type of funding. Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. 9/27/16, 2:09 p.m.

Avalon